DNTH dianthustx.com: Forvard P/S multiplikatori
Dianthus Therapeutics strategik biotexnologiya sherikliklari orqali yallig'lanishga qarshi kurashish uchun innovatsion antitanalarni ishlab chiqadi. Bashorat qilingan P/S ko'rsatkichi bozorning tushumlar bo'yicha kutganlarini baholash imkonini beradi va uning so'nggi qiymati 1893.10 deb qayd etilgan. Istiqbollar DNTH103 molekulasining xavfsizligi va kapital sarflash sur'atiga bog'liq, geosiyosiy omillar esa kompaniyaning klinik sinovlarini rivojlantirishga hech qanday ta'sir ko'rsatmaydi.
Dianthus Therapeutics, Inc. - tahliliy kesimlar va asosiy koʻrsatkichlar (DNTH)
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- emitentning balans qiymati statistikasi:
- kompaniyaning jami qarzi va likvidligi ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati Dianthus Therapeutics|DNTH - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Qisqa muddatli qarzning o'z kapitaliga nisbati Dianthus Therapeutics|DNTH - Kompaniyaning yig'indi qarzdorligi|Balans kapitallashuviga qarzlar Dianthus Therapeutics Inc|DNTH - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Dianthus Therapeutics|Tezkor likvidlik dianthustx.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
DNTH - Sof moliyaviy natija|Kelajakdagi foyda Dianthus Therapeutics|DNTH - Kompaniya qiymatining sof foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Dianthus Pharma|DNTH - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|EV/EBITDA multiplikatori Dianthus Therapeutics Inc|DNTH - Foizlar, soliqlar va amortizatsiya chegirilmasdan oldingi daromad|Bir aksiya uchun sof foyda (EPS TTM) Dianthus Therapeutics|DNTH - So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi dianthustx.com|DNTH - Joriy yilda bir aksiya uchun foyda ortishi|Keyingi yil uchun foyda o'sishi prognozi Dianthus Therapeutics
- realizatsiya hajmi va tushum ko'rsatkichlari:
Kompaniyaning umumiy tahlili:Dianthus Pharma DNTH
Dianthus Therapeutics (DNTH) yuqori xavfli immunoterapiya segmentida raqobatlashmoqda, bu yerda muvaffaqiyat klinik sinovlar natijalariga bog'liq. Forward P/S koeffitsiyenti kelajakdagi o'sish uchun premiumni aniqlash maqsadida joriy bozor kapitalizatsiyasini kutilayotgan savdo hajmi bilan solishtiradi. Bashorat qilingan narx-savdo koeffitsiyentini tahlil qilish investorlarning biotexnologiya loyihalarini moliyalashtirishga bo'lgan ishtiyoqini baholash imkonini beradi. Ushbu koeffitsiyentning dinamikasi bozor optimizmi va fundamental rivojlanish xavflari o'rtasidagi muvozanatni aks ettiradi.
Muhim raqobatchilar
Forvard P/S multiplikatori ARGX (argenx.com)|BioNTech Group (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|ABIVAX - Forvard P/S multiplikatori|ADMA - Forvard P/S multiplikatori|Protagonist (PTGX) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Immunovant Inc|Narxning prognoz qilingan daromadga nisbati Kiniksa Pharmaceuticals|Grifols Group (GRFS) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Adaptive Biotechnologies Corp (ADPT)|Narxning prognoz qilingan daromadga nisbati CLDX (Celldex Therapeutics)|Narxning prognoz qilingan daromadga nisbati Aurinia Pharma AUPH|Sotuvga nisbatan forvard narx BCRX|VERA: Forvard narx/daromad multiplikatori|PHVS - Forvard P/S multiplikatori|ABCL: Forvard P/S multiplikatori|TRML (Tourmaline Bio, Inc.) - Narxning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Intrexon|PHAR - Prognoz narxning daromadga nisbati|Forvard P/S multiplikatori NKTR|Narxning prognoz qilingan daromadga nisbati UPB (Upstream Bio Corp)|Narxning prognoz qilingan daromadga nisbati Zenas Biopharma, Inc. ZBIO|Kapitalizatsiyaning kutilayotgan sotuvga nisbati immunome.com (IMNM)|Gossamer Bio Inc - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx KALV (KalVista Pharmaceuticals, Inc.)|SEPN: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Pieris Pharmaceuticals Inc|Forvard narx/daromad multiplikatori SVRA|Forvard narx/daromad multiplikatori Rigel Pharmaceuticals (RIGL)|Forvard P/S multiplikatori ANAB|ATXS - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati enGene Corp ENGN|Kapitalizatsiyaning kutilayotgan sotuvga nisbati RAPT Therapeutics, Inc. (RAPT)|Aerovate - Forvard P/S multiplikatori|ACRS - Forvard P/S multiplikatori|KYTX (Kyverna Therapeutics) - Forvard narx/daromad multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Tiziana Life Sciences Ltd. (TLSA)|Forvard narx/daromad multiplikatori CABA|Ventyx Biosciences (VTYX) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori THTX|AVTX (Avalo Therapeutics, Inc) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori ELDN (eledon.com)|AGEN - Forvard narx/daromad multiplikatori|CLYM - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati ZURA|ATYR: Forvard P/S multiplikatori|Adagene Corp (ADAG) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori IMA|Shattuck Labs, Inc. - Kelajakdagi narxning daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Equillium Inc (EQ)|Forvard P/S multiplikatori Connect Biopharma Holdings (CNTB)|Narxning prognoz qilingan daromadga nisbati Immunic, Inc. IMUX|Forvard P/S multiplikatori Atara Biotherapeutics ATRA|IFRX - Narxning prognoz qilingan daromadga nisbati|XFOR: Narxning prognoz qilingan daromadga nisbati|ACET: Forvard P/S multiplikatori|CELU - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati inmunebio.com|Kapitalizatsiyaning prognoz qilingan daromadga nisbati BRNS (barinthusbio.com)|Forvard P/S multiplikatori KZR|Forvard P/S multiplikatori SAB Biotherapeutics, Inc (SABS)|Forvard P/S multiplikatori AKTX (Akari Therapeutics, Plc)|Forvard P/S multiplikatori enlivex.com ENLV|QTTB: Forvard narx/daromad multiplikatori|GOVX - Forvard P/S multiplikatori|Edesa Biotech Inc (EDSA) - Narxning prognoz qilingan daromadga nisbati|IBIO - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati carismatx.com|XTLB: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Bolt Biotherapeutics Inc. (BOLT)|HCW Biologics - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati aptevotherapeutics.com APVO|AIM - Forvard narx/daromad multiplikatori|Aditxt - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati GRI Bio Corporation GRI|xortx.com (XRTX) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati reshapelifesciences.com (HIND)|Narxning prognoz qilingan daromadga nisbati Revelation Bio|Bozor kapitallashuvining kelajakdagi daromadga nisbati Indaptus Therapeutics, Inc. INDP|Narxning prognoz qilingan daromadga nisbati BiondVax Pharmaceuticals (SCNI)|Forvard narx/daromad multiplikatori CalciMedica CALI|Narxning prognoz qilingan daromadga nisbati Affimed AFMD|ALLK - Forvard narx/daromad multiplikatori|HOOKIPA Pharma, Inc. - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx IGMS (igmbio.com)|ITOS (iTeos Therapeutics, Inc.) - Forvard narx/daromad multiplikatori|Ocean Biomedical Corp (OCEA) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati TC BioPharm (Holdings) PLC|Forvard P/S multiplikatori thirdharmonicbio.com
